Bioniq Health-tech Solutions

Bioniq was founded in early 2019 by former German national basketball player Vadim Fedotov and scientist and neurosurgeon Konstantin Karuzin, who spent more than 14 years conducting clinical trials of pharmacological drugs and technologies in Switzerland and Russia for companies such as GlaxoSmithKline and Pfizer.

History

2025: Construction of a plant for the production of protein bars together with Ipsum for 250 million rubles

In mid-November 2025, it became known that the medical company Bioniq and the manufacturer of biologically active additives (dietary supplement) Ipsum are implementing a project to build a joint plant. It is planned to produce protein bars, soufflé and electrolyte marmalade.

According to the Vedomosti newspaper, investments in the creation of the enterprise will amount to about 250 million rubles. Partners are considering several possible locations for the construction of the facility: the plant can be located in the Moscow region, in the Volga region or in the Caucasus.

𝓲

Фото: Freepik

It is assumed that the capacity of the factory at the initial stage will be 1,500 tons, or 30 million snacks per year. In the future, the volume of production will increase - as the range expands and market positions strengthen. A Bioniq spokesman said fitness snacks will go on sale in 2026. The products are planned to be distributed through the online stores of the manufacturers themselves, as well as marketplaces. In addition, the products will appear in offline retail.

On the one hand, as noted by the DSM Group, dietary supplements manufacturers rarely enter the food market, since this requires other equipment and relevant documentation. However, on the other hand, as indicated by the Union of Dietary Supplement Manufacturers (SRO SP Dietary Supplement), the segments of additives and functional nutrition are similar in terms of competencies and capacity. Therefore, the joint venture of Bioniq and dietary supplements Ipsum, according to experts from SRO SP Dietary Supplement, will be able to take a share in the segment, subject to investments in the promotion of new products, including high-quality advertising. Protein products attract consumers who pay attention to a healthy lifestyle: such people increasingly include functional snacks in their diet.^[1]

2022: Bioniq acquires German fitness start-up Vaha for €150m

On December 7, 2022, it became known about the sale of 100% Vaha to British to the vitamin manufacturer the Russian with the founders of Bioniq. The company did not disclose the fiance terms of the agreement. More. here

2021: Raising $15 million in investments

On January 13, 2021, it became known that Bioniq had attracted about $15 million in investments. Almost half of this amount - $7.2 million - was provided by AFK Sistema. In addition, the Luxembourg venture capital fund OKS Group invested in the developer of telemedicine services with the participation of a number of other investors (together they provided $7.8 million).

As clarifies Kommersant"," AFK Sistema invested in the Russian subsidiary of the British company Bioniq. The funds raised startup intend to spend on expanding DNA testing services and developing tools for maintaining psychological health. According to the chairman of the board of directors of the Russian subsidiary Bioniq, the Vadim Fedotova company will use the funds received to develop a project on DNA tests of its own development.

AFK Sistema invested $7.2 million in telemedicine services developer Bioniq

In addition, with the funding raised, Bioniq will complement the product line with personalized menus and tools to maintain psychological health. The growth of the company in the Russian medical services market is ensured by a partnership with a network of private clinics Medsi"," which is part of AFK Sistema, Fedotov said.

According to the GritDaily portal, the company focused on the Russian market thanks to cooperation with Medsi, but at the same time it intends to develop business in other countries. Axios, citing Bioniq, writes that an investment round A Series was held, and the money raised is planned to be spent on expanding the company's business in the United States and the Middle East.^[2][3][4]

2020: Creation of Bayonic-Medsi

At the end of February 2020, Medsi and Bioniq Health-tech Solutions announced the creation of the Bayonic-Medsi enterprise, within which the companies will develop a digital personalized system for monitoring and promoting public health. The new business will be headed by Vadim Fedotov, founder of the international company Bioniq Health-tech Solutions, formerly CEO of Gazprom-Media Technologies. Read more here.

Notes